Comments on: Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

Comments on: Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss https://thegbm.com/roche-presents-new-phase-iii-one-year-data-for-vamikibart-in-uveitic-macular-edema-ume-a-serious-cause-of-vision-loss/ Business news, opinion, reviews, interviews Sat, 10 Oct 2026 21:40:00 +0000 hourly 1 https://wordpress.org/?v=7.1.3